Clinical Trial Update: Study to Determine the Efficacy and Safety of ELS-M11 in Acute Migraine [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 study evaluating the efficacy and safety of ELS-M11 for acute migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• ELS-M11

Snippet

Sponsor: Achelios Therapeutics | Conditions: Migraine Headaches | Phase 1, Phase 2 | Status: COMPLETED